![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/IOLCP.png)
Share the post "IOL Chemicals And Pharmaceuticals ‘s Q3 2024-25 Latest News: Profit Falls by 11.54% Year-on-Year"
Highlights
🔹 The presented financial data is Standalone to provide a comprehensive overview of the company performance. 🔹 Sales over the Year and quarter: The company experienced a substantial growth of 0.56 % in the past year, decrease in net sales/revenue by -0.47 %. 🔹 Income over the Year and quarter: There has been decline in other income over the past year which is -51.43 %, Marginal decrease of -36.7% in other income during this quarter. 🔹 Profit over the Year and quarter: Challenges in sustaining profitability for IOL Chemicals and Pharmaceuticals Limited. Profit dropped by -11.54 % Year to Year, IOL Chemicals and Pharmaceuticals Limited’s profitability increased by 7.31 % in this quarter. 🔹 EPS over the Year and quarter: EPS declined by -11.62 % Year to Year. EPS increased by 7.36 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 520.39 Cr | Rs. 525.75 Cr | Rs. 523.3 Cr | -0.47 % | + 0.56 % |
| Expenses | Rs. 475.91 Cr | Rs. 484.19 Cr | Rs. 476.43 Cr | -1.6 % | + 0.11 % |
| Operating Profit | Rs. 44.48 Cr | Rs. 41.56 Cr | Rs. 46.87 Cr | + 12.78 % | + 5.37 % |
| OPM % | 8.55 % | 7.9 % | 8.96 % | + 1.06 % | + 0.41 % |
| Other Income | Rs. 8.38 Cr | Rs. 6.43 Cr | Rs. 4.07 Cr | -36.7 % | -51.43 % |
| Interest | Rs. 4.3 Cr | Rs. 4.12 Cr | Rs. 4.46 Cr | + 8.25 % | + 3.72 % |
| Depreciation | Rs. 16.32 Cr | Rs. 17.93 Cr | Rs. 18.66 Cr | + 4.07 % | + 14.34 % |
| Profit before tax | Rs. 32.24 Cr | Rs. 25.94 Cr | Rs. 27.82 Cr | + 7.25 % | -13.71 % |
| Tax % | 27.95 % | 26.18 % | 26.13 % | -0.05 % | -1.82 % |
| Net Profit | Rs. 23.23 Cr | Rs. 19.15 Cr | Rs. 20.55 Cr | + 7.31 % | -11.54 % |
| EPS in Rs | Rs. 3.96 | Rs. 3.26 | Rs. 3.5 | + 7.36 % | -11.62 % |
Today, we’re looking at IOL Chemicals and Pharmaceuticals Limited’s financial performance for the Q3(Dec 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 0.56 %. However, it did see a marginal slip of -0.47 % from the previous quarter. Expenses decreased slightly by -1.6 % quarter-on-quarter, aligning with the annual rise of 0.11 %. Operating profit, while up 5.37 % compared to last year, faced a quarter-on-quarter increase of 12.78 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 0.41 %, but an expansion of 1.06 % sequentially. Other income fell by -36.7 % compared to the last quarter, despite an annual decline of -51.43 %. Interest expenses surged remarkably by 8.25 % from the previous quarter, yet the year-over-year increase remains at a moderate 3.72 %. Depreciation costs climbed by 4.07 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 14.34 %. Profit before tax declined annually by -13.71 % but saw an increase from the preceding quarter by 7.25 %.
Tax expenses as a percentage of profits decreased slightly by -1.82 % compared to last year, with a more notable quarter-on-quarter decrease of -0.05 %. Net profit fell by -11.54 % year-on-year but experienced a 7.31 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -11.62 % but a quarterly rise of 7.36 %. In summary, IOL Chemicals and Pharmaceuticals Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 520.39 Cr | Rs. 525.75 Cr | Rs. 523.3 Cr | -0.47 % | + 0.56 % |
| Expenses | Rs. 475.91 Cr | Rs. 484.19 Cr | Rs. 476.43 Cr | -1.6 % | + 0.11 % |
| Operating Profit | Rs. 44.48 Cr | Rs. 41.56 Cr | Rs. 46.87 Cr | + 12.78 % | + 5.37 % |
| Net Profit | Rs. 23.23 Cr | Rs. 19.15 Cr | Rs. 20.55 Cr | + 7.31 % | -11.54 % |
| EPS in Rs | Rs. 3.96 | Rs. 3.26 | Rs. 3.5 | + 7.36 % | -11.62 % |
In reviewing IOL Chemicals and Pharmaceuticals Limited’s 2024-25(Q3) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 0.56 % year-on-year growth, although there was a slight dip of -0.47 % from the previous quarter. Expenses rose by 0.11 % compared to the previous year, with a decrease of -1.6 % quarter-on-quarter. Operating Profit surged by 5.37 % annually, and saw a 12.78 % increase from the last quarter.
Net Profit showed yearly decrease of -11.54 %, and experienced a 7.31 % increase from the previous quarter. Earnings Per Share (EPS) fell by -11.62 % annually, however rose by 7.36 % compared to the last quarter. In essence, while IOL Chemicals and Pharmaceuticals Limited faces strong annual decline indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/YAANENT.png)
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/MAHSEAMLES.png)
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/GSLSU.png)